From April 1, 2022 to June 30, 2022, the company has repurchased 79,620 shares, representing 0.03% for CNY 4.86 million. With this, the company has completed the repurchase of 759,620 shares, representing 0.24% for CNY 54.71 million under the buyback announced on February 7, 2022.
Qingdao Haier Biomedical Co.,Ltd
Equities
688139
CNE100003P25
Advanced Medical Equipment & Technology
End-of-day quote
Other stock markets
|
5-day change | 1st Jan Change | ||
39.71 CNY | -0.65% | +4.61% | -2.00% |
EPS Revisions
Annual profits - Rate of surprise
1st Jan change | Capi. | |
---|---|---|
-2.00% | 1.73B | |
+8.38% | 220B | |
+15.78% | 198B | |
+31.27% | 112B | |
+4.87% | 66.17B | |
+14.19% | 52.47B | |
+4.70% | 50.77B | |
-3.93% | 38.97B | |
-0.47% | 35.13B | |
+23.96% | 31.32B |
- Stock Market
- Equities
- 688139 Stock
- News Qingdao Haier Biomedical Co.,Ltd
- Tranche Update on Qingdao Haier Biomedical Co., Ltd's Equity Buyback Plan announced on February 7, 2022.